Cleared Abbreviated

K150513 - Imed Technology Intravascular Administr...

K150513 is an FDA 510(k) clearance for Imed Technology Intravascular Administr..., manufactured by Imed Technology, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Abbreviated 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2015
Decision
90d
Days
Class 2
Risk

K150513 is an FDA 510(k) clearance for the Imed Technology Intravascular Administration Set, Imed Technology Extension Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Imed Technology, Inc. (Carrollton, US). The FDA issued a Cleared decision on May 28, 2015 after a review of 90 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Imed Technology, Inc. devices

FDA 510(k) Submission Details - K150513

510(k) Number K150513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2015
Decision Date May 28, 2015
Days to Decision 90 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 129d · This submission: 90d
Pathway characteristics
Standards-based clearance path.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 513
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K150513.
BD FlowSmart Set, MiniMed Pro-Set
K153257 · Becton, Dickinson and Company · Dec 2015
Q2 Intravenous Adminstration Sets and Extension Sets
K151079 · Quest Medical, Inc. · Sep 2015
IV Administration Sets with 200(micro)m Blood Filter
K143082 · B.Braun Medical, Inc. · Jul 2015
Nitroglycerin Sets with DUO-VENT Spike
K150860 · Baxter Healthcare Corporation · Apr 2015
Hospira Blood Set
K143087 · Hospira, Inc. · Mar 2015
Hospira Primary Sets
K143015 · Hospira, Inc. · Feb 2015